The generic name of Terokai is Erlotinib Hydrochloride Tablets, which is a generation of targeted drugs. At present, targeted drugs are a more effective class of drugs for the treatment of tumors, and erlotinib hydrochloride tablets are mainly used for the treatment of lung cancer.
Erlotinib Hydrochloride Tablets are indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with sensitive mutations in the epidermal growth factor receptor (EGFR) gene. This includes first-line therapy, maintenance therapy, or second-line and above therapy after progression from at least one prior chemotherapy.
Erlotinib Hydrochloride Tablet is useful for the treatment of lung cancer, but some toxic side effects may occur during use, such as rash, diarrhea, dyspnea, cough, fever and so on. In addition, people who are allergic to erlotinib hydrochloride tablets should be prohibited from using it to avoid adverse consequences.
The treatment of lung cancer is complicated, and Erlotinib Hydrochloride Tablets cannot ensure that it can cure lung cancer, and many side effects will occur. Therefore, lung cancer patients should not use medicine blindly, and should consult doctor in time and listen to professional doctor’s advice.